122 related articles for article (PubMed ID: 9473017)
1. Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera.
Devito C; Levi M; Hinkula J; Fernandez Medina RD; Libonatti O; Wigzell H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):156-9. PubMed ID: 9473017
[TBL] [Abstract][Full Text] [Related]
2. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
Sherefa K; Sällberg M; Sönnerborg A
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
[TBL] [Abstract][Full Text] [Related]
3. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing.
Nkengasong JN; Willems B; Janssens W; Cheingsong-Popov R; Heyndrickx L; Barin F; Ondoa P; Fransen K; Goudsmit J; van der Groen G
AIDS; 1998 Aug; 12(12):1405-12. PubMed ID: 9727560
[TBL] [Abstract][Full Text] [Related]
5. Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.
Warren RQ; Wong MT; Melcher GP; Blatt SP; Cahn P; Perez H; Zapiola I; Bouzas MB; Muchinik G; Anderson SA
J Clin Microbiol; 1995 Feb; 33(2):481-3. PubMed ID: 7714212
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
[TBL] [Abstract][Full Text] [Related]
7. Relative reactivity of the V3 loop PND of HIV-1 subtypes A, B, C, D, and F with sera from selected Ugandan localities.
Riley JP; Pestano GA; Hosford K; Francis C; Xie JM; Mugyenyi P; Kataaha P; Katongole-Mbidde E; Anokbonggo WW; Guyden J
Arch Virol; 1995; 140(8):1393-404. PubMed ID: 7544970
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping.
Hoelscher M; Hanker S; Barin F; Cheingsong-Popov R; Dietrich U; Jordan-Harder B; Olaleye D; Nägele E; Markuzzi A; Mwakagile D; Minja F; Weber J; Gürtler L; Von Sonnenburg F
AIDS Res Hum Retroviruses; 1998 Jan; 14(2):139-49. PubMed ID: 9462924
[TBL] [Abstract][Full Text] [Related]
9. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.
Pau CP; Lee-Thomas S; Auwanit W; George JR; Ou CY; Parekh BS; Granade TC; Holloman DL; Phillips S; Schochetman G
AIDS; 1993 Mar; 7(3):337-40. PubMed ID: 8471195
[TBL] [Abstract][Full Text] [Related]
10. Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.
Cheingsong-Popov R; Osmanov S; Pau CP; Schochetman G; Barin F; Holmes H; Francis G; Ruppach H; Dietrich U; Lister S; Weber J
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):311-8. PubMed ID: 9519892
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions.
Peeters M; Nkengasong J; Willems B; Karita E; Delaporte E; Van den Haesevelde M; Piot P; van der Groen G
AIDS; 1994 Dec; 8(12):1657-61. PubMed ID: 7888113
[TBL] [Abstract][Full Text] [Related]
12. V3 serotyping of HIV-1 infection: correlation with genotyping and limitations.
Plantier JC; Damond F; Lasky M; Sankalé JL; Apetrei C; Peeters M; Buzelay L; M'Boup S; Kanki P; Delaporte E; Simon F; Barin F
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):432-41. PubMed ID: 10225224
[TBL] [Abstract][Full Text] [Related]
13. Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.
Pestano GA; Hosford KS; Spira AI; Riley J; Xie JM; Sewankambo N; Brown L; Ho DD; Boto WM
AIDS Res Hum Retroviruses; 1995 May; 11(5):589-96. PubMed ID: 7576915
[TBL] [Abstract][Full Text] [Related]
14. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
15. Correlation between anti-V3 peptide and neutralizing antibodies in plasma from HIV-1 infected individuals resident in Brazil.
Bongertz V; Morgado MG; Galvão-Castro B; Wigzell H; Hendry RM
Mem Inst Oswaldo Cruz; 1994; 89(1):113-4. PubMed ID: 7823807
[TBL] [Abstract][Full Text] [Related]
16. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.
Cheingsong-Popov R; Lister S; Callow D; Kaleebu P; Beddows S; Weber J
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1379-86. PubMed ID: 7888191
[TBL] [Abstract][Full Text] [Related]
17. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
18. An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera.
Gómez CE; López-Campistrous AE; Duarte CA
J Virol Methods; 1998 Mar; 71(1):7-16. PubMed ID: 9628216
[TBL] [Abstract][Full Text] [Related]
19. Characterization of sera from subjects infected with HIV-1 subtypes B and E in Thailand by antibody binding and neutralization.
Louisirirotchanakul S; Beddows S; Cheingsong-Popov R; Shaffer N; Mastro TD; Auewarakul P; Likanonsakul S; Wasi C; Weber J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):315-20. PubMed ID: 9833739
[TBL] [Abstract][Full Text] [Related]
20. Peptide serology for analysis of the inter- and intra-individual variation in the HIV-1 V3 domain.
Jansson M; Wahren B; Albert J; Scarlatti G; Franzén L; Kataaha PK; Katabira E; Mubiro F; Wigzell H; Rossi P
AIDS; 1994 Apr; 8(4):413-21. PubMed ID: 8011244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
